In 2005, the U.S. Court of Appeals for the Eleventh Circuit issued its opinion vacating the judgment of the trial court and erasing an $18 million lost profits award against...
The National Law Journal selected Hollingsworth LLP three times in seven years for its Top Ten Defense Wins list, including for its success in Crowson v. Davol, a major medical...
In 2005, the U.S. Court of Federal Claims (“CFC”) issued its decision in the Winstar-related case, Caroline Hunt Trust Estate v. United States, a breach of contract action that was...
The U.S. District Court for the District of New Mexico issued its 67-page final summary judgment opinion dismissing the State of New Mexico’s natural resource damages claims against the Firm’s...
Joe Hollingsworth, national trial and appellate counsel for Novartis Pharmaceuticals Corp. in the Parlodel litigation, is featured in a supplement to The American Lawyer and Corporate Counsel magazines, “The Future...
The U.S. Court of Appeals for the Eleventh Circuit unanimously affirmed the grant of summary judgment to client, Novartis Pharmaceuticals in Rider/Siharath v. Sandoz Pharm. Corp., 131 F. Supp. 2d...
In March 2000, the U.S. District Court for the Western District of Oklahoma entered summary judgment for Sandoz Pharmaceuticals Corporation, holding that the plaintiff’s proffered expert testimony that Parlodel caused...
Following a two-day evidentiary Daubert hearing in Caraker v. Sandoz Pharm. Corp., 172 F. Supp. 2d 1046 (S.D. Ill. 2001), Judge J. Phil Gilbert granted Firm client Sandoz’s motion to...
In a unanimous decision, the 8th Circuit affirmed the grant of summary judgment to Novartis in Glastetter v. Novartis Pharmaceuticals Corp., 252 F.3d 986 (8th Cir. 2001). This significant Daubert...
March 19, 2001 by Emily Heller For litigators who defend, winning summary judgment is about as good as it gets. To many, it’s even more satisfying than a favorable jury...
The U.S. District Court for the Northern District of Georgia issued a 69-page Daubert opinion in favor of our client in Rider/Siharath v. Sandoz Pharmaceuticals Corp., 131 F. Supp. 2d...